FluoroEthylNorMemantine (FENM)

FluoroEthylNorMemantine · ReST Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FluoroEthylNorMemantine (FENM), covering 2024-05-03 to 2024-05-03. Get the full timeline:

Most recent: Clinical Trial Update: First-In-Human (FIH), Single Ascending Dose (SAD) Study of FluoroEthylNorMemantine (FENM) [Phase 1]